載入...

Zarxio (Filgrastim-sndz): The First Biosimilar Approved by the FDA

Zarxio (filgrastim-sndz), a biosimilar for the treatment of severe chronic neutropenia

Na minha lista:
書目詳細資料
發表在:P T
Main Authors: Awad, Mina, Singh, Pavit, Hilas, Olga
格式: Artigo
語言:Inglês
出版: MediMedia USA, Inc. 2017
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5215272/
https://ncbi.nlm.nih.gov/pubmed/28090158
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!